Kisspeptin Research: What Published Studies Have Investigated

What is kisspeptin?

What is kisspeptin? It is a family of peptides — kisspeptin-54, -14, -13 and -10 — cleaved from the roughly 145-amino-acid product of the KISS1 gene, all sharing an Arg-Phe-amide (RF-amide) C-terminus. Kisspeptins are the endogenous ligands of the receptor KISS1R, also called GPR54. They were first characterized as ligands of GPR54 by Kotani et al. (2001, J Biol Chem); KISS1 was originally identified as a metastasis-suppressor gene, which is why the early literature also calls the product “metastin.” That is a neutral molecular definition; the sections below describe what researchers examined, not effects in people.

Molecule properties

Kisspeptin-54 is the full 54-residue form (the “metastin”), while the shorter C-terminal fragments — kisspeptin-10 being the minimal active core — retain the RF-amide motif required for receptor binding. The naming reflects residue length, so kisspeptin-14 and kisspeptin-13 sit between the full-length and minimal forms, and each is defined by where the parent peptide is cleaved. Endogenously, kisspeptins arise in hypothalamic neurons; for laboratory work the peptide is catalogued in synthetic, research-grade lyophilized form, which is the distinction between the naturally occurring signaling peptide and the material supplied for study. These are molecule facts only — no handling or reconstitution instructions are given here.

Mechanisms researchers have examined

The kisspeptin mechanism literature is comparatively well documented for a catalog peptide, and it centres on receptor signaling and neuroendocrine regulation. Each direction below is framed as what researchers examined:

• KISS1R / GPR54 receptor signaling — Kotani et al. (2001, J Biol Chem, PMID 11457843) reported that kisspeptins bind KISS1R (GPR54), a Gq/11-coupled receptor, and that this drives PIP2 hydrolysis, intracellular Ca²⁺ mobilization, and ERK1/2 and p38 MAP-kinase phosphorylation in the systems studied.
• Upstream regulation of GnRH neurons — studies positioned kisspeptin-expressing hypothalamic neurons (in the arcuate and AVPV nuclei) as upstream drivers of gonadotropin-releasing-hormone (GnRH) neuron activity, characterizing kisspeptin as a proximate stimulus within the HPG axis.
• Genetic gatekeeper of pubertal onset — de Roux et al. (2003, PNAS, PMID 12944565) and Seminara et al. (2003, NEJM, PMID 14573733) independently reported that loss-of-function mutations in GPR54/KISS1R associate with isolated hypogonadotropic hypogonadism in humans and mice, framing the receptor as essential for normal GnRH physiology.
• Signaling-family context — kisspeptin is described in the literature as the endogenous KISS1R agonist within the broader RF-amide peptide biology.

The section closes as the literature does: kisspeptin is an upstream neuroendocrine signaling peptide whose mechanisms have been characterized in cell, animal, and — for HPG-axis responses — human research models. Each bullet names a pathway examined, not an effect in a reader.

Research models in the literature

On the preclinical side, the mechanistic work rests on heterologous cell systems expressing rat or human GPR54 (Kotani 2001) and on rodent and human genetics of GPR54/KISS1R loss- and gain-of-function (de Roux 2003; Seminara 2003). The genetic studies are notable because they read the pathway in reverse: rather than adding kisspeptin and watching a response, they identified people and mice in whom the receptor does not work and observed the associated neuroendocrine phenotype, which is how the receptor came to be described as essential for normal GnRH physiology. Kisspeptin is unusual among catalog compounds in also having an investigational human research record, largely from the Imperial College London group, and those studies are described here strictly by what they measured rather than any promised result.

• Dhillo et al. (2005, J Clin Endocrinol Metab, PMID 16174713) — a placebo-controlled study in healthy men that measured plasma LH, FSH and testosterone after an intravenous kisspeptin-54 infusion.
• Jayasena, Abbara, Comninos, Dhillo et al. (2014, J Clin Invest, PMID 25036713) — a study in women undergoing in-vitro fertilization that investigated whether a single kisspeptin-54 injection could trigger oocyte maturation, and reported neuroendocrine and clinical measures.
• Comninos et al. (2017, J Clin Invest, PMID 28112678) — a functional-neuroimaging study that examined limbic brain activity in healthy men during administration of kisspeptin versus vehicle.

It is worth stating plainly: these are investigational research studies, not approved treatments. Kisspeptin is not a marketed therapy, and none of these findings is an outcome offered to a reader. A study that measured LH or examined brain activity is a record of what was investigated in a controlled setting — it does not establish that a reader would experience any effect, and the neuroendocrine and reproductive endpoints those papers report are described here only as research observations.

Kisspeptin among the neuroendocrine peptides

What distinguishes kisspeptin as a research target is its position in the HPG axis: it sits upstream of GnRH and the downstream gonadotropins, so the literature frames it as a proximate gatekeeper of that signaling cascade rather than a downstream effector. That upstream-gatekeeper framing is a research-focus comparison, not stacking or use advice — it explains why kisspeptin is studied as an entry point into GnRH physiology while other neuroendocrine peptides act at different tiers of the same axis. For a related neuroendocrine-peptide explainer, see Tesamorelin research; for another peptide whose literature touches receptor and pigmentation-adjacent neuroendocrine signaling, see Melanotan-2 research. This page hands off to those siblings rather than rebuilding their detail here.

Research-grade sourcing and verification

For laboratory research use only, kisspeptin is supplied with a per-batch Certificate of Analysis reporting HPLC purity (%) and mass-spec identity confirmation, verifiable at the lot level. Check the exact batch on the self-serve verify tool, and see how to read a COA for what the certificate reports. This is sourcing and quality-assurance framing only, focused on identity and purity for research use rather than any outcome.

Frequently asked questions

Literature cited

1. Kotani M, Detheux M, Vandenbogaerde A, et al. “The Metastasis Suppressor Gene KiSS-1 Encodes Kisspeptins, the Natural Ligands of the Orphan G Protein-coupled Receptor GPR54.” J Biol Chem. 2001;276(37):34631–6. PMID 11457843.
2. de Roux N, Genin E, Carel JC, et al. “Hypogonadotropic Hypogonadism Due to Loss of Function of the KiSS1-Derived Peptide Receptor GPR54.” PNAS. 2003;100(19):10972–6. PMID 12944565.
3. Seminara SB, Messager S, Chatzidaki EE, et al. “The GPR54 Gene as a Regulator of Puberty.” N Engl J Med. 2003;349(17):1614–27. PMID 14573733.
4. Dhillo WS, Chaudhri OB, Patterson M, et al. “Kisspeptin-54 Stimulates the Hypothalamic-Pituitary Gonadal Axis in Human Males.” J Clin Endocrinol Metab. 2005;90(12):6609–15. PMID 16174713.
5. Jayasena CN, Abbara A, Comninos AN, et al. (Dhillo WS). “Kisspeptin-54 Triggers Egg Maturation in Women Undergoing In Vitro Fertilization.” J Clin Invest. 2014;124(8):3667–77. PMID 25036713.
6. Comninos AN, Wall MB, Demetriou L, et al. “Kisspeptin Modulates Sexual and Emotional Brain Processing in Humans.” J Clin Invest. 2017;127(2):709–19. PMID 28112678.
7. Review context: “Comprehensive Review on Kisspeptin and Its Role in Reproductive Disorders.” 2015. PMC4508256.